A detailed history of Woodard & CO Asset Management Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Woodard & CO Asset Management Group Inc holds 8,440 shares of ABBV stock, worth $1.42 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
8,440
Previous 8,540 1.17%
Holding current value
$1.42 Million
Previous $1.32 Million 16.1%
% of portfolio
0.42%
Previous 0.4%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $15,982 - $18,210
-100 Reduced 1.17%
8,440 $1.54 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $15,763 - $18,248
-118 Reduced 1.36%
8,540 $1.27 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $15,636 - $19,458
118 Added 1.38%
8,658 $1.17 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $8,676 - $9,992
-60 Reduced 0.7%
8,540 $1.36 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $22,129 - $26,539
160 Added 1.9%
8,600 $1.39 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $43,350 - $55,112
-315 Reduced 3.6%
8,440 $1.29 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $26,395 - $32,750
-200 Reduced 2.23%
8,755 $1.42 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $18,800 - $23,787
175 Added 1.99%
8,955 $1.21 Million
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $3,436 - $4,033
40 Added 0.46%
8,780 $769,000
Q2 2020

Jul 24, 2020

BUY
$73.37 - $98.18 $22,011 - $29,454
300 Added 3.55%
8,740 $858,000
Q1 2020

Apr 27, 2020

BUY
$64.5 - $97.79 $7,095 - $10,756
110 Added 1.32%
8,440 $643,000
Q4 2019

Jan 24, 2020

BUY
$72.13 - $90.25 $6,491 - $8,122
90 Added 1.09%
8,330 $738,000
Q3 2019

Oct 22, 2019

BUY
$62.98 - $75.72 $44,086 - $53,004
700 Added 9.28%
8,240 $624,000
Q4 2018

Feb 01, 2019

SELL
$77.85 - $96.01 $54,494 - $67,207
-700 Reduced 8.5%
7,540 $695,000
Q4 2017

Feb 16, 2018

BUY
$89.56 - $98.21 $737,974 - $809,250
8,240
8,240 $797,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Woodard & CO Asset Management Group Inc Portfolio

Follow Woodard & CO Asset Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodard & CO Asset Management Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Woodard & CO Asset Management Group Inc with notifications on news.